Quality key factors
Factor
Value
Sales Growth (5y)
22.24%
EBIT Growth (5y)
-0.50%
EBIT to Interest (avg)
0.30
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.62
Tax Ratio
17.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.23%
ROE (avg)
7.11%
Valuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.95
EV to EBIT
16.18
EV to EBITDA
15.06
EV to Capital Employed
1.88
EV to Sales
2.11
PEG Ratio
0.49
Dividend Yield
NA
ROCE (Latest)
3.10%
ROE (Latest)
6.75%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Movement
8What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 5.6 times
DEBTORS TURNOVER RATIO(HY)
Highest at 6.49 times
NET SALES(Q)
Highest at EUR 5 MM
OPERATING PROFIT(Q)
Highest at EUR 0.99 MM
PRE-TAX PROFIT(Q)
Highest at EUR 0.75 MM
-6What is not working for the Company
INTEREST(HY)
At EUR 0.03 MM has Grown at 138.2%
RAW MATERIAL COST(Y)
Grown by 9.25% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 8.83 %
Here's what is working for Laboratorio Farmaceutico Erfo SpA
Net Sales
At EUR 5 MM has Grown at 58.95%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (EUR MM)
Net Sales
Highest at EUR 5 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (EUR MM)
Operating Profit
Highest at EUR 0.99 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (EUR MM)
Pre-Tax Profit
Highest at EUR 0.75 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (EUR MM)
Pre-Tax Profit
At EUR 0.75 MM has Grown at 87.94%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (EUR MM)
Inventory Turnover Ratio
Highest at 5.6 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 6.49 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Laboratorio Farmaceutico Erfo SpA
Interest
At EUR 0.03 MM has Grown at 138.2%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (EUR MM)
Debt-Equity Ratio
Highest at 8.83 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 9.25% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






